Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

AGN-193080, a peripherally acting alpha2-agonist from Allergan

Sep. 20, 1996

Xalatan Solution now available for glaucoma

Sep. 20, 1996

U.S. approval for glaucoma medication

Sep. 13, 1996

Potent antiinflammatory/antioxidant agents from Alcon

Aug. 30, 1996

Study finds latanoprost more effective than timolol

Aug. 30, 1996

Glaucoma diagnostic under investigation in Germany

Aug. 23, 1996

Cannabinoid receptor ligands for glaucoma reported by Merck Frosst

Aug. 16, 1996

Cefazolin/fluoroquinolone combinations show favorable antibacterial activity

July 26, 1996

Fujisawa claims tacrolimus as allergic conjunctivitus treatment

July 26, 1996

Ciclosporin demonstrates efficacy and safety as an antimetabolite

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...